Last 12 months
Inside the activity.
2 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantPerformance Rights · Derivative | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000015 · wf-form4_161368825264795.xml · derivative · entry 5 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,120 Underlying: Common Stock · 73,000 shares Expires not disclosed F4 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 106,190 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000015 · wf-form4_161368825264795.xml · derivative · entry 4 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,423 Underlying: Common Stock · 106,190 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000015 · wf-form4_161368825264795.xml · derivative · entry 3 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,233 Underlying: Common Stock · 73,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Rowe Robert ScottDirector · President & CEO
|
Tax withholdingCommon Stock | 25,815 | $39.18 | $1,011,431.70 |
DisclosureSEC source: 0000030625-21-000015 · wf-form4_161368825264795.xml · nonDerivative · entry 2 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,436 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 65,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000030625-21-000015 · wf-form4_161368825264795.xml · nonDerivative · entry 1 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Morytko TamaraPresident, FPD
|
GrantPerformance Rights · Derivative | 9,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000014 · wf-form4_161368823667639.xml · derivative · entry 3 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,290 Underlying: Common Stock · 9,290 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Morytko TamaraPresident, FPD
|
GrantRestricted Stock Units · Derivative | 6,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000014 · wf-form4_161368823667639.xml · derivative · entry 2 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,930 Underlying: Common Stock · 6,640 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:44 UTC |
Morytko TamaraPresident, FPD
|
GrantRestricted Stock Units · Derivative | 9,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000014 · wf-form4_161368823667639.xml · derivative · entry 1 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,290 Underlying: Common Stock · 9,290 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
GrantPerformance Rights · Derivative | 9,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000013 · wf-form4_161368821459850.xml · derivative · entry 3 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,290 Underlying: Common Stock · 9,290 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
GrantRestricted Stock Units · Derivative | 5,310 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000013 · wf-form4_161368821459850.xml · derivative · entry 2 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,876 Underlying: Common Stock · 5,310 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
GrantRestricted Stock Units · Derivative | 9,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000013 · wf-form4_161368821459850.xml · derivative · entry 1 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,566 Underlying: Common Stock · 9,290 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Exercise / conversionPerformance Rights · Derivative | 11,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000012 · wf-form4_161368818526223.xml · derivative · entry 6 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,440 Underlying: Common Stock · 11,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
GrantPerformance Rights · Derivative | 7,960 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000012 · wf-form4_161368818526223.xml · derivative · entry 5 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,080 Underlying: Common Stock · 7,960 shares Expires not disclosed F4 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
GrantRestricted Stock Units · Derivative | 7,960 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000012 · wf-form4_161368818526223.xml · derivative · entry 4 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,770 Underlying: Common Stock · 7,960 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
GrantRestricted Stock Units · Derivative | 7,960 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000012 · wf-form4_161368818526223.xml · derivative · entry 3 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,810 Underlying: Common Stock · 7,960 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Tax withholdingCommon Stock | 2,901 | $39.18 | $113,661.18 |
DisclosureSEC source: 0000030625-21-000012 · wf-form4_161368818526223.xml · nonDerivative · entry 2 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,325 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:43 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Exercise / conversionCommon Stock | 11,583 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000030625-21-000012 · wf-form4_161368818526223.xml · nonDerivative · entry 1 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Chowbey SanjayPresident, AMSS
|
GrantPerformance Rights · Derivative | 6,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000011 · wf-form4_161368814940000.xml · derivative · entry 3 Chowbey Sanjay · CIK 0001782435 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,900 Underlying: Common Stock · 6,640 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Chowbey SanjayPresident, AMSS
|
GrantRestricted Stock Units · Derivative | 5,310 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000011 · wf-form4_161368814940000.xml · derivative · entry 2 Chowbey Sanjay · CIK 0001782435 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,210 Underlying: Common Stock · 5,310 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Chowbey SanjayPresident, AMSS
|
GrantRestricted Stock Units · Derivative | 6,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000011 · wf-form4_161368814940000.xml · derivative · entry 1 Chowbey Sanjay · CIK 0001782435 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,900 Underlying: Common Stock · 6,640 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Burger ElizabethChief Human Resources Officer
|
Exercise / conversionPerformance Rights · Derivative | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000010 · wf-form4_161368811990683.xml · derivative · entry 6 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,530 Underlying: Common Stock · 8,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Burger ElizabethChief Human Resources Officer
|
GrantPerformance Rights · Derivative | 9,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000010 · wf-form4_161368811990683.xml · derivative · entry 5 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,930 Underlying: Common Stock · 9,290 shares Expires not disclosed F4 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% based on performance against two factors over a three-year performance cycle beginning on January 1, 2021 and ending on December 31, 2023: 1) the issuer's three year average free cash flow ("FCF") as a percentage of net income; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. Additionally, a relative total shareholder return ("TSR") modifier will be applied that may result in a positive or negative 15% adjustment to the otherwise earned performance rights. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Burger ElizabethChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 13,270 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000010 · wf-form4_161368811990683.xml · derivative · entry 4 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,479 Underlying: Common Stock · 13,270 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus and dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus and dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus and dividends accrued on the underlying shares). The restricted stock units vest over a three-year period, with one-third vesting on the second anniversary of the grant and the remaining two-thirds vesting on the third anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Burger ElizabethChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 9,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-21-000010 · wf-form4_161368811990683.xml · derivative · entry 3 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,209 Underlying: Common Stock · 9,290 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Burger ElizabethChief Human Resources Officer
|
Tax withholdingCommon Stock | 3,278 | $39.18 | $128,432.04 |
DisclosureSEC source: 0000030625-21-000010 · wf-form4_161368811990683.xml · nonDerivative · entry 2 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,411 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:42 UTC |
Burger ElizabethChief Human Resources Officer
|
Exercise / conversionCommon Stock | 8,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000030625-21-000010 · wf-form4_161368811990683.xml · nonDerivative · entry 1 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 93.6% (plus dividends accrued on the underlying shares) based on two factors over a three-year performance cycle beginning on January 1, 2018 and ending on December 31, 2020 which are: 1) the issuer's relative total share holder return ("TSR") in comparison to the TSR averages of a predetermined peer group over the performance cycle; and 2) the issuer's return on invested capital measured against the issuer's performance relative to its weighted average cost of capital and relative to a predetermined peer group over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 21:39 UTC |
Chand SujeetDirector
|
GrantPhantom Stock · Derivative | 858 | $33.53 | $28,768.74 |
DisclosureSEC source: 0000030625-20-000122 · wf-form4_160616757788172.xml · derivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,353 Underlying: Common Stock · 858 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 21:39 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 858 | $33.53 | $28,768.74 |
DisclosureSEC source: 0000030625-20-000121 · wf-form4_160616755914642.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,414 Underlying: Common Stock · 858 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 21:39 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 188 | $33.53 | $6,303.64 |
DisclosureSEC source: 0000030625-20-000120 · wf-form4_160616754150276.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,385 Underlying: Common Stock · 188 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| August 10, 2020 Filed Aug 10, 2020 21:20 UTC |
Chand SujeetDirector
|
GrantPhantom Stock · Derivative | 936 | $30.70 | $28,735.20 |
DisclosureSEC source: 0000030625-20-000109 · wf-form4_159709440419408.xml · derivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,495 Underlying: Common Stock · 936 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| August 10, 2020 Filed Aug 10, 2020 21:19 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 207 | $30.70 | $6,354.90 |
DisclosureSEC source: 0000030625-20-000107 · wf-form4_159709436857157.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,197 Underlying: Common Stock · 207 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| August 10, 2020 Filed Aug 10, 2020 21:20 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 936 | $30.70 | $28,735.20 |
DisclosureSEC source: 0000030625-20-000108 · wf-form4_159709438630225.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,556 Underlying: Common Stock · 936 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:40 UTC |
Chowbey SanjayPresident, AMSS
|
Exercise / conversionRestricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-20-000097 · wf-form4_159493563628731.xml · derivative · entry 3 Chowbey Sanjay · CIK 0001782435 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,260 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:40 UTC |
Chowbey SanjayPresident, AMSS
|
Tax withholdingCommon Stock | 250 | $30.67 | $7,667.50 |
DisclosureSEC source: 0000030625-20-000097 · wf-form4_159493563628731.xml · nonDerivative · entry 2 Chowbey Sanjay · CIK 0001782435 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,625 Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:40 UTC |
Chowbey SanjayPresident, AMSS
|
Exercise / conversionCommon Stock | 1,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-20-000097 · wf-form4_159493563628731.xml · nonDerivative · entry 1 Chowbey Sanjay · CIK 0001782435 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:41 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-20-000093 · wf-form4_159199446923210.xml · derivative · entry 3 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,276 Underlying: Common Stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:41 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 675 | $27.00 | $18,225.00 |
DisclosureSEC source: 0000030625-20-000093 · wf-form4_159199446923210.xml · nonDerivative · entry 2 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,078 Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:41 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 2,769 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-20-000093 · wf-form4_159199446923210.xml · nonDerivative · entry 1 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:50 UTC |
Chand SujeetDirector
|
GrantPhantom Stock · Derivative | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000088 · wf-form4_159052620164328.xml · derivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,559 Underlying: Common Stock · 2,628 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:49 UTC |
Roberts David E JrDirector
|
GrantPhantom Stock · Derivative | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000087 · wf-form4_159052617982475.xml · derivative · entry 1 Roberts David E Jr · CIK 0001363218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,882 Underlying: Common Stock · 2,628 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:49 UTC |
McMurray Michael C.Director
|
GrantPhantom Stock · Derivative | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000086 · wf-form4_159052615801863.xml · derivative · entry 1 McMurray Michael C. · CIK 0001556386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,196 Underlying: Common Stock · 2,628 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:49 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000085 · wf-form4_159052613629808.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,620 Underlying: Common Stock · 2,628 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:48 UTC |
FRIEDERY JOHN RDirector
|
GrantCommon Stock | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000084 · wf-form4_159052611451512.xml · nonDerivative · entry 1 FRIEDERY JOHN R · CIK 0001271363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,664 F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 22, 2021. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:48 UTC |
FIX ROGER LDirector
|
GrantCommon Stock ($1.25 par value per share) | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000083 · wf-form4_159052609416917.xml · nonDerivative · entry 1 FIX ROGER L · CIK 0001163373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,308 F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 22, 2021. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:48 UTC |
DELLY GAYLA JDirector
|
GrantCommon Stock | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000082 · wf-form4_159052607195063.xml · nonDerivative · entry 1 DELLY GAYLA J · CIK 0001218358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,196 F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 22, 2021. Read SEC document |
| May 22, 2020 Filed May 26, 2020 20:47 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 2,628 | $25.20 | $66,225.60 |
DisclosureSEC source: 0000030625-20-000081 · wf-form4_159052605189031.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,990 Underlying: Common Stock · 2,628 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:35 UTC |
Chand SujeetDirector
|
GrantPhantom Stock · Derivative | 1,247 | $23.05 | $28,743.35 |
DisclosureSEC source: 0000030625-20-000072 · wf-form4_158957490008001.xml · derivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,931 Underlying: Common Stock · 1,247 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:34 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 1,247 | $23.05 | $28,743.35 |
DisclosureSEC source: 0000030625-20-000071 · wf-form4_158957487862198.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,992 Underlying: Common Stock · 1,247 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:34 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 275 | $23.05 | $6,338.75 |
DisclosureSEC source: 0000030625-20-000070 · wf-form4_158957485562364.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,362 Underlying: Common Stock · 275 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:33 UTC |
Burger ElizabethChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 667 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-20-000062 · wf-form4_158715558622983.xml · derivative · entry 3 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,919 Underlying: Common Stock · 667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on the date of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on the date of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.